| If this is not your name, click here. | | |
| | Contact Us | Order Now | Journals | Bookstore | Register a colleague | | |
| | | ![]() Xalatan Approved In Japan For Glaucoma And Ocular Hypertension BRIDGEWATER, NJ -- March 15, 1999 -- Pharmacia & Upjohn’s once-a-day glaucoma medication, Xalatan(TM) Sterile Ophthalmic Solution has been approved by Japan's Ministry of Health & Welfare for the treatment of glaucoma and ocular hypertension. Xalatan has been approved in more than 57 countries and is the leading prescribed glaucoma medication in several markets, including the United States. Xalatan is related to a class of compounds called prostaglandins that are present in various forms throughout the body. Prostaglandins act locally to increase drainage of aqueous humor, the fluid behind the eye's intraocular lens and reduce intraocular pressure. Lowering intraocular pressure through topical treatments is the standard of care in treating glaucoma. Related Links: Xalatan, Pharmacia & Upjohn
|